Patent · US Active

Anti-leishmanial compound and anti-leishmanial drug

US8373006B2 · kind B2 · utility

1Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 8, 2011
Grant dateFeb 12, 2013
Priority date—
Expiry dateMar 8, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided is an anti-leishmanial compound represented by formula (3):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.